>>> Specifically, management is evaluating several paths to revenue generation that follow different timelines, including production of AquAdvantage [®] fish at the Company's existing farm in Panama, purchase of an existing production facility in North America, and construction of a new production facility in North America. <<<
Not having to use antibiotics and vaccines in their salmon will be a big selling point that will help balance out the GMO aspect from a consumer acceptance standpoint. And their land-based approach appears to have many advantages over the traditional open-sea cage fish farming method -
>>> Our game-changing platform affords better economics for land-based aquaculture and all the advantages that it brings, including nutritious Atlantic salmon free of antibiotics, vaccines, and other treatments that are necessary to minimize infection in fish farming today," added Dr. Stotish <<<
http://www.marketwatch.com/story/aquabounty-announces-completion-of-nasdaq-listing-and-equity-subscription-from-intrexon-2017-01-19?siteid=bigcharts&dist=bigcharts
Recent AQB News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:04:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 01:13:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 01:03:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 12:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:44:07 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/01/2023 10:08:56 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/01/2023 10:05:27 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 09:14:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:07:19 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/04/2023 11:24:55 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2023 12:44:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:36:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:05:53 PM
- AquaBounty Announces a Pause to Ohio Farm Construction While It Evaluates Scope Alternatives and a Possible Phased Approach • GlobeNewswire Inc. • 06/02/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM